MDCG revision 5 clarifies IVDR Rule 7 for control materials
Summary
Revision 5 updates the Rule 7 rationale and examples.
The evidence
Revision 5 updates the Rule 7 rationale and examples.
For controls intended for IVD procedures, unassigned controls fall under Rule 7, class B unless other rules apply; manufacturer-assigned controls follow implementing rule 1.6.
Standalone QC materials do not replace mandatory controls for verifying the IVD itself.
Interpretation and limitations
This guidance is non-binding; it does not automatically classify RUO products.
Intended purpose and the complete applicable rules determine classification.
What this means for laboratories
CFCM analysis: review control IFUs and distinguish assigned values from indicative ranges before assessing local implications.
Source Date
September 9, 2026
Event date
September 9, 2026
Commercial Regulatory Status
Published non-binding guidance; no new statutory effective date inferred
Primary source
Read the source →An announcement is not proof of availability or authorisation. Interpret status within the stated jurisdiction and evidence boundary.
Editor and independence disclosure →CFCM WEEKLY · EVERY SUNDAY
The science behind the signal, in your inbox.
Get evidence-led clinical flow cytometry news, original conference posters, figures from published papers, practical learning pills, an advanced quiz and the story of one CD marker each week. Free. No spam.
Get CFCM Weekly →Complete the form and confirm the email we send you. Unsubscribe any time. Privacy policy.